Status: current, Not sufficiently defined by necessary conditions definition status. Date: 06-Jan 2016. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 96012701000001111 | Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 96012801000001119 | Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | VMP prescribing status (attribute) | Caution - AMP level prescribing advised | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Is a | Fluticasone 500micrograms/actuation / Salmeterol 50micrograms/actuation dry powder inhaler 60 dose | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Has AMP | Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Has specific active ingredient | Salmeterol xinafoate | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Has specific active ingredient | Fluticasone propionate | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Has dispensed dose form | Conventional release powder for inhalation | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Salmeterol | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Discontinued indicator | Never discontinued | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | VMP prescribing status (attribute) | VMP not recommended to prescribe - patient training required | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Discontinued indicator | Discontinued AMPP(qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (A A H Pharmaceuticals Ltd) 60 dose | Has basis of strength substance | Salmeterol | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR